There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
The alleged hacking follows reports of similar attacks on other Democratic organisations, amid fears of state-sponsored hacking.
One lucky ticket holder based in the UK has won a cool £61 million jackpot in the EuroMillions lottery game.
A crowdfunding campaign has been set up to raise money needed for a legal battle to bring home Michael Sandford.